Another study showed that excessive activation of BRD4 could promote epithelial-mesenchymal transition (EMT) in prostate cancer cells, thus promoting prostate cancer cell metastasis, which JQ1 could be used to effectively block this process, thereby exerting antitumor effects (Blee et al., 2016). Here, BRD4 is linked to prostate cancer.